WOWp Zomedica Corp

PCG Research Announces Publication of Report Covering Zomedica Pharmaceuticals Corp.

Developer of Diagnostic and Pharmaceutical Solutions for the Companion Animal Market with Commercialization Activities Approaching

New York, New York--(Newsfile Corp. - September 11, 2019) - PCG Research, the equity research division of PCG Advisory, Inc., a leading investor relations and strategic advisory firm based in New York City and focused on small and micro-cap public companies, today announced it has initiated coverage on Zomedica Pharmaceuticals, Corp. (NYSE: ZOM)

The report is available here:

"Zomedica is currently focused on investigating strategies for North America and global commercialization of diagnostics for the companion animal market, as well as developing a therapeutic pharmaceutical pipeline. The company expects initial commercialization activities in its diagnostic product lines to begin during 2020. Its pharmaceutical pipeline and drug delivery methods are in development, and we expect them to begin pivotal studies in the second half of 2019, with additional catalysts and milestones over the next few years," commented Jeff Ramson, CEO of PCG Advisory. "Zomedica is also positioned to make advancements on the corporate development front in coming quarters. We are excited about their addition to our recently launched company sponsored equity research platform and look forward to tracking the company's progress."

ABOUT ZOMEDICA PHARMACEUTICALS CORP.

Zomedica is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. For more information, visit .

ABOUT PCG RESEARCH

PCG Research offers issuer-sponsored research that is based on objective, fact-based analysis, written by experienced CFA analysts, and strategically distributed to the investment community utilizing targeted distribution channels as well as social media and private distribution relationships.

PCG Research is an affiliate of PCG Advisory, Inc. PCG Advisory is a leading investor relations firm dedicated to the delivery of top-tier strategic services that encompass investor relations, capital markets navigation, and corporate communications for innovative and emerging growth companies from around the globe. PCG Advisory has extensive experience with life science, cannabis, alternative energy and technology companies.

PCG Research is also an affiliate of PCG Digital Enterprises, LLC. PCG Digital owns, partners with and/or licenses innovative aggregation, distribution, and engagement platforms. PCG Digital reaches thousands of individual, retail and institutional investors and stakeholders through its proprietary and extensive distribution network as well as through the use of unique multimedia marketing and audience development techniques. PCG Digital, via its subsidiary, PCG Productions, produces management interviews, highlight and informational clips to further enhance and showcase our client companies. Videos are filmed with robust production resources in PCG's NYC office.

Please see our full disclosures in the body of the report and on our website: .

Contact:

PCG Research
646-863-6341

To view the source version of this press release, please visit

EN
11/09/2019

Underlying

WOWpZomedica Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Zomedica Corp

 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Appoints Larry Heaton as President and Announces CEO Successi...

Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan ANN ARBOR, Mich., Oct. 04, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that Larry Heaton has been appointed President effective October 1, 2021. Mr. Heaton will assume the role of Chief Executive Officer upon the retirement of current Chief Executive Officer Robert Cohen on October 31, 2021. Following his retirement, Mr. Cohen will remain on the Board of ...

October 4, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Acquires PulseVet

Zomedica Acquires PulseVet ANN ARBOR, Mich., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that it had acquired the Pulse Veterinary Technologies businesses for $70.9 million in an all-cash, stock transaction. Pulse Veterinary Technologies (“PulseVet”) is a world leader in electro-hydraulic shock wave technology for the treatment of a wide variety of conditions in veterinary patients. The high-energy sound w...

October 1, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Sean Whelan Appointed to Board of Directors

Sean Whelan Appointed to Board of Directors ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to fill the vacancy created by the resignation of Christopher Wolfenberg. Robert Cohen, Zomedica’s Chief Executive Officer, commented that: “We all are very pleased to be joined by an executive with Sean’s sterling background. His broad and deep experience and expert...

September 13, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Announces Second Quarter 2021 Financial Results

Zomedica Announces Second Quarter 2021 Financial Results TRUFORMA® Instrument Placement Program Implemented to Incentivize Future Assay Sales ANN ARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the three and six months ended June 30, 2021. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of Americ...

August 11, 2021 1 EN
 PRESS RELEASE
Free
WOWp ZOMEDICA CORP

Zomedica Announces 2021 Annual Meeting Results

Zomedica Announces 2021 Annual Meeting Results ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) --  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for companion animals, today announced the voting results of its 2021 Annual Virtual-Only Meeting of Shareholders (the “Meeting”) held on July 30, 2021. At the Meeting, the Company’s shareholders approved the items of business as follows: Election of Jeffrey Rowe, Robert Cohen, Johnny D. Powers, Rodney Williams, Chris MacLeod and Christopher Wolfenberg as directors; ...

July 30, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch